SERVIER PERINDOPRIL ARGININE PLUS 10/2,5 TABLET Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

servier perindopril arginine plus 10/2,5 tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains indapamide 2,5 mg perindopril arginine 10,0 mg

DOMION agomelatine 25 mg film-coated tablet blister pack. Australien - engelsk - Department of Health (Therapeutic Goods Administration)

domion agomelatine 25 mg film-coated tablet blister pack.

servier laboratories (aust) pty ltd - agomelatine, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; stearic acid; colloidal anhydrous silica; sodium starch glycollate type a; maize starch; lactose monohydrate; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; indigo carmine aluminium lake; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; glycerol - treatment in adults of: - of major depression (mdd) including prevention of relapse - generalised anxiety disorder (gad)

LATUDA lurasidone hydrochloride 80 mg film-coated tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

latuda lurasidone hydrochloride 80 mg film-coated tablet blister pack

servier laboratories (aust) pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hypromellose; pregelatinised maize starch; carnauba wax; magnesium stearate; mannitol; iron oxide yellow; indigo carmine; titanium dioxide; macrogol 6000 - latuda is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LATUDA lurasidone hydrochloride 40 mg film-coated tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

latuda lurasidone hydrochloride 40 mg film-coated tablet blister pack

servier laboratories (aust) pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; carnauba wax; magnesium stearate; mannitol; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; macrogol 6000 - latuda is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

INDOSYL MONO 4  perindopril erbumine 4mg tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

indosyl mono 4 perindopril erbumine 4mg tablet blister pack

servier laboratories (aust) pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; hydrophobic colloidal silica anhydrous; magnesium stearate - indosyl mono is indicated for: the treatment of hypertension; indosyl mono is indicated for: the treatment of heart failure. in such patients it is recommended that indosyl mono be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of indosyl mono has not been demonstrated for new york heart association category iv patients) indosyl mono is indicated for: patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.